General Psychiatry - Articles - Page 119

Are Depot Antipsychotics More Effective than Oral Meds? Maybe

April 1, 2011

Section editor, Glen Spielmans, PhD

Clinical folklore (and occasional drug reps) have suggested that depot antipsychotics have adherence advantages over their oral counterparts.

Learning Objectives, Antidepressant Roundup 2011, TCPR, April 2011

April 1, 2011

After reading these articles, you should be able to…

The DSM-5: A Guide to Coming Changes

March 1, 2011

Daniel Carlat, MD

Sometime in 2013, we’ll presumably be forced to shell out a hundred bucks or so for the fifth edition of DSM. While we do not have the space to review every potential change here, we will cover those of most clinical importance.

Let’s Get Real: Media Alarmism vs the Data on Prevalence of Psychiatric Disorders in the U.S.

March 1, 2011

Let’s Get Real: Media Alarmism vs the Data on Prevalence of Psychiatric Disorders in the U.S.

Psychiatry Epidemiology

March 1, 2011

We often hear that 20% to 30% of Americans have a mental illness. What is that figure based on?

Do Placebos Work Even When Patients Know They are Placebos?

March 1, 2011

Section editor, Glen Spielmans, PhD

It’s commonly known across all fields of medicine, psychiatry included, that in clinical trials, placebo treatment works, in some cases just as well as “real” treatment.

Learning Objectives, DSM-5 and Diagnostic Issues, TCPR, March 2011

March 1, 2011

After reading these articles, you should be able to…

Drug Interactions in Psychiatry: A Practical Review

February 1, 2011

Jessica L. Gören, PharmD, BCPP and Daniel Carlat, MD

Jessica L. Gören, PharmD, BCPP Associate professor, University of Rhode Island Instructor in Psychiatry, Harvard University Clinical psychiatric pharmacist, Cambridge Health Alliance Daniel Carlat, MD Associate clinical professor, Tufts University School of Medicine Dr. Goren and Dr. Carlat have disclosed that they have no relevant relationships or financial interests in any commercial company pertaining to this educational activity.

In this article we’ll survey those drug interactions that are most likely to become troublesome in day to day psychiatric practice.

Drug-Drug Interactions

February 1, 2011

Neil Sandson, MD

Neil Sandson, MD. Clinical associate professor, Department of Psychiatry, University of Maryland School of Medicine; Staff psychiatrist, VA Maryland Health Care System.
Dr. Sandson has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.educational activity.

It seems that drug-drug interactions (DDI) were in our profession’s consciousness more in the past than they are now. Is this because we have less to worry about than we used to?

Atypicals No Better Than Typicals in Depression with Schizophrenia

February 1, 2011

Second generation antipsychotics have developed a reputation for being more effective for treating a number of the symptoms of schizophrenia than their first generation counterparts, even if research doesn’t always back up this claim.

General Psychiatry
RSS

Are Depot Antipsychotics More Effective than Oral Meds? Maybe

Learning Objectives, Antidepressant Roundup 2011, TCPR, April 2011

The DSM-5: A Guide to Coming Changes

Let’s Get Real: Media Alarmism vs the Data on Prevalence of Psychiatric Disorders in the U.S.

Psychiatry Epidemiology

Do Placebos Work Even When Patients Know They are Placebos?

Learning Objectives, DSM-5 and Diagnostic Issues, TCPR, March 2011

Drug Interactions in Psychiatry: A Practical Review

Drug-Drug Interactions

Atypicals No Better Than Typicals in Depression with Schizophrenia

Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

Psychopharm Secrets: Coming Off Meds

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

Join Our Writing Team

Insights About a Rare Transmissible Form of Alzheimer's Disease

How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry RSS

About

Shop Online

Newsletters

Contact

Follow Us

General Psychiatry
RSS